WOCNext 2019

Amniox Medical, Inc. 

Booth 505

Miami, FL  
      United States





Amniox Medical, a pioneer in regenerative therapies, was the first company to provide a cryopreserved human umbilical cord allograft for wound treatment. Our proprietary CRYOTEK process is the only proven method to produce a matrix equivalent to the native tissue, delivering the unique benefits of the innate biology to orchestrate regenerative healing of chronic wounds.





The company’s flagship wound care product, NEOX CORD 1K, is more potent and persistent than products with amniotic membrane alone. It also features unmatched thickness for superior handling, excellent handling and easy application.  Unlike other cryopreserved products, NEOX can safely refrigerated for up to 2 years without compromising its structural or functional integrity. 



Product Categories

- Tissue-based